Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Valerie Quarmby, Qui T Phung & Jennie R Lill. (2018) MAPPs for the identification of immunogenic hotspots of biotherapeutics; an overview of the technology and its application to the biopharmaceutical arena. Expert Review of Proteomics 15:9, pages 733-748.
Read now
Read now
Sri H. Ramarathinam, Nathan P. Croft, Patricia T. Illing, Pouya Faridi & Anthony W. Purcell. (2018) Employing proteomics in the study of antigen presentation: an update. Expert Review of Proteomics 15:8, pages 637-645.
Read now
Read now
Articles from other publishers (23)
Charlotte Adams, Kris Laukens, Wout Bittremieux & Kurt Boonen. (2023) Machine learning‐based peptide‐spectrum match rescoring opens up the immunopeptidome. PROTEOMICS.
Crossref
Crossref
Jörg Christoph Prinz. (2023) Immunogenic self-peptides - the great unknowns in autoimmunity: Identifying T-cell epitopes driving the autoimmune response in autoimmune diseases. Frontiers in Immunology 13.
Crossref
Crossref
Tysheena Charles, Daniel L. Moss, Pawan Bhat, Peyton W. Moore, Nicholas A. Kummer, Avik Bhattacharya, Samuel J. Landry & Ramgopal R. Mettu. (2022) CD4+ T-Cell Epitope Prediction by Combined Analysis of Antigen Conformational Flexibility and Peptide-MHCII Binding Affinity. Biochemistry 61:15, pages 1585-1599.
Crossref
Crossref
Raphael Trevizani, Zhen Yan, Jason A Greenbaum, Alessandro Sette, Morten Nielsen & Bjoern Peters. (2022) A comprehensive analysis of the IEDB MHC class-I automated benchmark. Briefings in Bioinformatics 23:4.
Crossref
Crossref
Jörg Christoph Prinz. (2022) Antigen Processing, Presentation, and Tolerance: Role in Autoimmune Skin Diseases. Journal of Investigative Dermatology 142:3, pages 750-759.
Crossref
Crossref
Zeynep Koşaloğlu-Yalçın, Jenny Lee, Jason Greenbaum, Stephen P. Schoenberger, Aaron Miller, Young J. Kim, Alessandro Sette, Morten Nielsen & Bjoern Peters. (2022) Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions. iScience 25:2, pages 103850.
Crossref
Crossref
Christophe Desterke, Ali G. Turhan, Annelise Bennaceur-Griscelli & Frank Griscelli. (2021) HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease. Journal of Translational Medicine 19:1.
Crossref
Crossref
Zeynep Koşaloğlu‐Yalçın, John Sidney, William Chronister, Bjoern Peters & Alessandro Sette. (2020) Comparison of HLA ligand elution data and binding predictions reveals varying prediction performance for the multiple motifs recognized by HLA‐DQ2.5. Immunology 162:2, pages 235-247.
Crossref
Crossref
Brian Reardon, Zeynep Koşaloğlu-Yalçın, Sinu Paul, Bjoern Peters & Alessandro Sette. (2021) Allele-Specific Thresholds of Eluted Ligands for T-Cell Epitope Prediction. Molecular & Cellular Proteomics 20, pages 100122.
Crossref
Crossref
Dilki Wickramarachchi, Gregory Steeno, Zhiping You, Saleem Shaik, Christopher Lepsy & Li Xue. (2020) Fit-for-Purpose Validation and Establishment of Assay Acceptance and Reporting Criteria of Dendritic Cell Activation Assay Contributing to the Assessment of Immunogenicity Risk. The AAPS Journal 22:5.
Crossref
Crossref
Mareike Wendorff, Heli M. Garcia Alvarez, Thomas Østerbye, Hesham ElAbd, Elisa Rosati, Frauke Degenhardt, Søren Buus, Andre Franke & Morten Nielsen. (2020) Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction. Frontiers in Immunology 11.
Crossref
Crossref
Nathan P. Croft. (2020) Peptide Presentation to T Cells: Solving the Immunogenic Puzzle. BioEssays 42:3, pages 1900200.
Crossref
Crossref
Sinu Paul, Alba Grifoni, Bjoern Peters & Alessandro Sette. (2020) Major Histocompatibility Complex Binding, Eluted Ligands, and Immunogenicity: Benchmark Testing and Predictions. Frontiers in Immunology 10.
Crossref
Crossref
Sheridan Martini, Morten Nielsen, Bjoern Peters & Alessandro Sette. (2019) The Immune Epitope Database and Analysis Resource Program 2003–2018: reflections and outlook. Immunogenetics 72:1-2, pages 57-76.
Crossref
Crossref
Jasmine Davda, Paul Declerck, Siwen Hu-Lieskovan, Timothy P. Hickling, Ira A. Jacobs, Jeffrey Chou, Shahram Salek-Ardakani & Eugenia Kraynov. (2019) Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Zackery A. G. Knowlden, Katherine A. Richards, Savannah A. Moritzky & Andrea J. Sant. (2019) Peptide Epitope Hot Spots of CD4 T Cell Recognition Within Influenza Hemagglutinin During the Primary Response to Infection. Pathogens 8:4, pages 220.
Crossref
Crossref
René H. M. Raeven, Elly van Riet, Hugo D. Meiring, Bernard Metz & Gideon F. A. Kersten. (2019) Systems vaccinology and big data in the vaccine development chain. Immunology 156:1, pages 33-46.
Crossref
Crossref
Sandeep Kumar Dhanda, Randi Vita, Brendan Ha, Alba Grifoni, Bjoern Peters & Alessandro Sette. (2018) ImmunomeBrowser: a tool to aggregate and visualize complex and heterogeneous epitopes in reference proteins. Bioinformatics 34:22, pages 3931-3933.
Crossref
Crossref
Sinu Paul, Edita Karosiene, Sandeep Kumar Dhanda, Vanessa Jurtz, Lindy Edwards, Morten Nielsen, Alessandro Sette & Bjoern Peters. (2018) Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands. Frontiers in Immunology 9.
Crossref
Crossref
David Gfeller & Michal Bassani-Sternberg. (2018) Predicting Antigen Presentation—What Could We Learn From a Million Peptides?. Frontiers in Immunology 9.
Crossref
Crossref
Juliane Liepe, Huib Ovaa & Michele Mishto. (2018) Why do proteases mess up with antigen presentation by re-shuffling antigen sequences?. Current Opinion in Immunology 52, pages 81-86.
Crossref
Crossref
Renata Blatnik, Nitya Mohan, Maria Bonsack, Lasse G. Falkenby, Stephanie Hoppe, Kathrin Josef, Alina Steinbach, Sara Becker, Wiebke M. Nadler, Marijana Rucevic, Martin R. Larsen, Mogjiborahman Salek & Angelika B. Riemer. (2018) A Targeted LC‐MS Strategy for Low‐Abundant HLA Class‐I‐Presented Peptide Detection Identifies Novel Human Papillomavirus T‐Cell Epitopes. PROTEOMICS 18:11, pages 1700390.
Crossref
Crossref
Amanda L. Creech, Ying S. Ting, Scott P. Goulding, John F.K. Sauld, Dominik Barthelme, Michael S. Rooney, Terri A. Addona & Jennifer G. Abelin. (2018) The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction. PROTEOMICS 18:12, pages 1700259.
Crossref
Crossref